INIS
antibodies
100%
patients
53%
comparative evaluations
51%
performance
46%
covid-19
38%
sensitivity
36%
evaluation
35%
vaccines
35%
proteins
31%
detection
30%
coronaviruses
26%
antigens
25%
doses
24%
reviews
23%
viruses
22%
specificity
22%
messenger-rna
21%
diseases
20%
laboratories
19%
administration
19%
kinetics
18%
levels
17%
immunoassay
16%
populations
16%
control
16%
data
14%
electrophoresis
13%
symptoms
13%
biological markers
12%
values
11%
workers
11%
elisa
11%
assessments
11%
receptors
11%
capacity
11%
immunoglobulins
10%
interference
10%
testing
10%
concentration
10%
capillaries
9%
medicine
9%
dimers
9%
immunity
8%
neutrophils
8%
women
8%
dynamics
7%
peaks
6%
validation
6%
correlations
6%
pcr
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
60%
Neutralizing Antibody
46%
Monospecific Antibody
28%
Omicron Coronavirus Variant
23%
Vaccine Efficacy
19%
COVID-19
18%
Antibody Response
17%
Vaccination Policy
16%
Immunoglobulin G Antibody
16%
Binding Antibody
15%
Humoral Immunity
15%
Spike
12%
Virus Neutralization
12%
Titer
10%
Neutralization
9%
Immunoglobulin M Antibody
9%
Immunogenicity
9%
Breakthrough Infection
6%
Cross-Reactivity
6%
Drug Dose Regimen
6%
Antibody Titer
6%
Receptor Binding
5%
Viral Load
5%
Serology
5%
Keyphrases
BNT162b2
9%
Bivalent Boosters
9%
XBB.1.5
6%
Breakthrough Infection
6%
Subvariant
5%